Very nice expanded table, Rockyground. What is interesting is that these NPV economic calculations assume a discounting of future cashflows to the point that once you get past about 15 years, the cashflow is assumed to be worth very little.
In my view, the NPV model is ultra conservative and useful in terms of making economic decisions, but completely underplays the potential value which the market will ascribe in the future.
There will be far more exciting valuations down the track!!
- Forums
- ASX - By Stock
- PLS
- Ann: Outstanding PFS Results 5Mtpa Expansion
Ann: Outstanding PFS Results 5Mtpa Expansion, page-64
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.02 |
Change
-0.040(1.31%) |
Mkt cap ! $9.090B |
Open | High | Low | Value | Volume |
$3.08 | $3.11 | $3.02 | $55.82M | 18.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 424619 | $3.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.03 | 17344 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 329137 | 3.020 |
23 | 502241 | 3.010 |
92 | 359053 | 3.000 |
16 | 98735 | 2.990 |
19 | 101042 | 2.980 |
Price($) | Vol. | No. |
---|---|---|
3.040 | 32598 | 6 |
3.050 | 109743 | 7 |
3.060 | 104622 | 7 |
3.070 | 137237 | 8 |
3.080 | 1849 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online